PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-811X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma ; volume:20 ; number:1 ; day:24 ; month:11 ; year:2022 ; pages:1-19 ; date:12.2022
Cell communication and signaling ; 20, Heft 1 (24.11.2022), 1-19, 12.2022
- Urheber
-
Corrales, Eyleen
Levit Zerdoun, Ella
Metzger, Patrick
Mertes, Ralf
Lehmann, Ariane
Münch, Julia
Lemke, Steffen
Kowar, Silke
Börries, Melanie
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-022-00989-y
- URN
-
urn:nbn:de:101:1-2023020621290816858596
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Corrales, Eyleen
- Levit Zerdoun, Ella
- Metzger, Patrick
- Mertes, Ralf
- Lehmann, Ariane
- Münch, Julia
- Lemke, Steffen
- Kowar, Silke
- Börries, Melanie
- SpringerLink (Online service)
Ähnliche Objekte (12)
PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma
Extrazelluläre Effekte des Ca2+-bindenden Proteins S100A1 : grundlegende Experimente zur Morphologie und Funktion neonataler Kardiomyozyten in Abhängigkeit der Kulturbedingungen
Das Verbundprojekt "Personalisierte Medizin für die Onkologie" (PM4Onco) als Teil der Medizininformatik-Initiative (MII) : = The collaborative project "Personalized medicine for oncology" (PM4Onco) as part of the Medical Informatics Initiative (MII)
BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation
Blind normalization of public high-throughput databases
Molecular characterisation of tumours and biomarker identification for personalised radiation oncology using genomic data of patients with locally advanced head and neck squamous cell carcinoma
Systems medicine in the scope of multi omics analyses
Sondersituation der Daten in der Onkologie : = Data complexity in oncology
Understanding the mTOR signaling pathway via mathematical modeling
Bcl‐xL as prognostic marker and potential therapeutic target in cholangiocarcinoma
The impact of pre‐pregnancy folic acid intake on placental DNA methylation in a fortified cohort
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma
Extrazelluläre Effekte des Ca2+-bindenden Proteins S100A1 : grundlegende Experimente zur Morphologie und Funktion neonataler Kardiomyozyten in Abhängigkeit der Kulturbedingungen
Das Verbundprojekt "Personalisierte Medizin für die Onkologie" (PM4Onco) als Teil der Medizininformatik-Initiative (MII) : = The collaborative project "Personalized medicine for oncology" (PM4Onco) as part of the Medical Informatics Initiative (MII)
BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation
Blind normalization of public high-throughput databases
Molecular characterisation of tumours and biomarker identification for personalised radiation oncology using genomic data of patients with locally advanced head and neck squamous cell carcinoma
Systems medicine in the scope of multi omics analyses
Sondersituation der Daten in der Onkologie : = Data complexity in oncology
Understanding the mTOR signaling pathway via mathematical modeling
Bcl‐xL as prognostic marker and potential therapeutic target in cholangiocarcinoma
The impact of pre‐pregnancy folic acid intake on placental DNA methylation in a fortified cohort
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma
Extrazelluläre Effekte des Ca2+-bindenden Proteins S100A1 : grundlegende Experimente zur Morphologie und Funktion neonataler Kardiomyozyten in Abhängigkeit der Kulturbedingungen
Das Verbundprojekt "Personalisierte Medizin für die Onkologie" (PM4Onco) als Teil der Medizininformatik-Initiative (MII) : = The collaborative project "Personalized medicine for oncology" (PM4Onco) as part of the Medical Informatics Initiative (MII)
BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation
Blind normalization of public high-throughput databases
Molecular characterisation of tumours and biomarker identification for personalised radiation oncology using genomic data of patients with locally advanced head and neck squamous cell carcinoma
Systems medicine in the scope of multi omics analyses
Sondersituation der Daten in der Onkologie : = Data complexity in oncology
Understanding the mTOR signaling pathway via mathematical modeling
Bcl‐xL as prognostic marker and potential therapeutic target in cholangiocarcinoma
The impact of pre‐pregnancy folic acid intake on placental DNA methylation in a fortified cohort